Literature DB >> 6778386

Synthesis of 3-O-demethylfortimicins.

J R Martin, P Johnson, J Tadanier, A Goldstein.   

Abstract

Treatment of fortimicin B with lithium in ethylamine gave 3-O-demethylfortimicin B. The latter was converted by methodology developed with fortimicin B to 3-O-demethylfortimicin A, 4-N-sarcosyl-3-O-demethylfortimicin B, 4-N-beta-alanyl-3-O-demethylfortimicin B, and 4-N-(beta-aminoethyl)-3-O-demethylfortimicin B. 3-O-demethylfortimicin A and the 4-N-acyl-3-O-demethylfortimicins B had appreciably higher antibacterial activities than the corresponding parent fortimicins. Most significant was the increased activity of 3-O-demethylfortimicin A relative to fortimicin A against a variety of strains of Pseudomonas aeruginosa.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 6778386      PMCID: PMC284088          DOI: 10.1128/AAC.18.5.761

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  8 in total

1.  Fortimicins A and B, new aminoglycoside antibiotics. I. Producing organism, fermentation and biological properties of fortimicins.

Authors:  T Nara; M Yamamoto; I Kawamoto; K Takayama; R Okachi; S Takasawa; T Sato; S Sato
Journal:  J Antibiot (Tokyo)       Date:  1977-07       Impact factor: 2.649

2.  Fortimicins A and B, new aminoglycoside antibiotics. III. Structural identification.

Authors:  R S Egan; R S Stanaszek; M Cirovic; S L Mueller; J Tadanier; J R Martin; P Collum; A W Goldstein; R L De Vault; A C Sinclair; E E Fager; L A Mitscher
Journal:  J Antibiot (Tokyo)       Date:  1977-07       Impact factor: 2.649

3.  Fortimicins A and B, new aminoglycoside antibiotics. IV. In vitro study of fortimicin A compared with other aminoglycosides.

Authors:  R L Girolami; J M Stamm
Journal:  J Antibiot (Tokyo)       Date:  1977-07       Impact factor: 2.649

4.  Fortimicin A: collaborative in vitro susceptibility. Comparison with amikacin and gentamicin against 11,840 clinical bacterial isolates.

Authors:  R N Jones; A L Barry; P C Fuchs; T L Gavan; H M Sommers; E H Gerlach
Journal:  Antimicrob Agents Chemother       Date:  1979-12       Impact factor: 5.191

5.  Compound A49759, the 3-O-demethyl derivative of fortimicin A: in vitro comparison with six other aminoglycoside antibiotics.

Authors:  R N Jones; C Thornsberry; A L Barry; R R Packer; C N Baker; R E Badal
Journal:  Antimicrob Agents Chemother       Date:  1980-11       Impact factor: 5.191

6.  Comparative antimicrobial activity of O-demethylfortimicin A, a derivative of fortimicin A.

Authors:  R L Girolami; J M Stamm
Journal:  Antimicrob Agents Chemother       Date:  1980-11       Impact factor: 5.191

7.  4-N-acylfortimicins B and the preparation of fortimicin A from fortimicin B.

Authors:  J Tadanier; J R Martin; P Kurath; A W Goldstein; P Johnson
Journal:  Carbohydr Res       Date:  1980-02       Impact factor: 2.104

8.  Chemical modification of fortimicins: preparation of 4-N-substituted fortimicin B.

Authors:  M Sato; Y Mori
Journal:  J Antibiot (Tokyo)       Date:  1979-04       Impact factor: 2.649

  8 in total
  4 in total

1.  Compound A49759, the 3-O-demethyl derivative of fortimicin A: in vitro comparison with six other aminoglycoside antibiotics.

Authors:  R N Jones; C Thornsberry; A L Barry; R R Packer; C N Baker; R E Badal
Journal:  Antimicrob Agents Chemother       Date:  1980-11       Impact factor: 5.191

2.  Comparative antimicrobial activity of O-demethylfortimicin A, a derivative of fortimicin A.

Authors:  R L Girolami; J M Stamm
Journal:  Antimicrob Agents Chemother       Date:  1980-11       Impact factor: 5.191

3.  In vitro and in vivo antibacterial activities of K-4619, a new semisynthetic aminoglycoside.

Authors:  Y Saino; Y Hattori; T Koshi; F Kobayashi; T Oda; S Mitsuhashi
Journal:  Antimicrob Agents Chemother       Date:  1984-08       Impact factor: 5.191

4.  3-0-demethyl fortimicin A: in vitro activity and interpretive zone standards for disk diffusion susceptibility tests.

Authors:  A L Barry; R N Jones; C Thornsberry; T L Gavan; E H Gerlach; H M Sommer
Journal:  Eur J Clin Microbiol       Date:  1984-12       Impact factor: 3.267

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.